Tue, Aug 30th 2016, 17:44
You may have come to this web site given that you have received documentation from an insurance company requesting that a treatment readiness assessment be done as a requirement for prior authorization for medication to treat hepatitis C.In most cases, the insurance company will give the choice between conducting the PREP-C assessment or using SAMHSA-HRSA Center for Integrated Health Solutions – Drug & Alcohol Screening Tools. A link to these tools is provided in the Resources Section of the PrepC.org site under ‘Alcohol and Substance Use’ Resources.You do not have to register at this site to access these resources.
The PREP-C assessment was developed to assess potential barriers to patients successfully adhering to and completing hepatitis C treatment. This information can be helpful to the medical provider allowing for necessary referrals and interventions prior to starting treatment (e.g., mental health treatment, treatment education) as well as guidance as to best equip the patient with needed tools during treatment (e.g., medication reminders). If your clinical impression is that the patient may have some barriers to adhering to and completing HCV treatment, administering the PREP-C can be of great value. If however, your clinical impression is that the patient does not have any barriers to treatment adherence or completion then the most efficient strategy tp meet the Prior Authorization requirement is to administer one of the SAMHSA-HRSA screening tools (e.g., CAGE-AID) which consists of only four questions.